102049-4
Hereditary sensory and autonomic neuropathy type 1 panel - Serum by LC/MS/MS
Active
102054-4 1-deoxymethylsphingosine [Mass/volume] in Serum by LC/MS/MS
Fully-Specified Name
- Component
- 1-deoxymethylsphingosine
- Property
- MCnc
- Time
- Pt
- System
- Ser
- Scale
- Qn
- Method
- LC/MS/MS
Basic Attributes
- Class
- CHEM
- Type
- Laboratory
- First Released
- Version 2.75
- Last Updated
- Version 2.75 (ADD)
- Order vs. Observation
- Observation
Formula (Readable)
Reference value <=0.09
Member of these Panels
| LOINC | Long Common Name |
|---|---|
| 102049-4 | Hereditary sensory and autonomic neuropathy type 1 panel - Serum by LC/MS/MS |
Language Variants Get Info
| Tag | Language | Translation |
|---|---|---|
| cs-CZ | Czech (Czechia) | 1-deoxymethylsfingosin: |
| el-GR | Greek (Greece) | 1-δεοξυμεθυλοσφιγγοσίνη: Synonyms: 1-δεοξυμεθυλοσφιγγοσίνη CHEM LC/MS/MS MCnc Pt Qn Ορός |
| es-ES | Spanish (Spain) | 1-desoximetilesfingosina: Synonyms: Cuantitativo |
| fr-FR | French (France) | 1-déoxyméthylsphingosine: |
| it-IT | Italian (Italy) | 1-deossimetilsfingosina: Synonyms: Chimica Concentrazione di Massa Punto nel tempo (episodio) Siero |
| nl-NL | Dutch (Netherlands) | 1-deoxymethylsfingosine: |
| pl-PL | Polish (Poland) | 1-Deoksymetylosfingozyna: |
| zh-CN | Chinese (China) | 1-脱氧甲基神经鞘胺醇: Synonyms: 1-脱氧甲基(神经)鞘胺醇; |
Example Units
| Unit | Source |
|---|---|
| ng/mL | Example UCUM Units |
102053-6 1-deoxymethylsphinganine [Mass/volume] in Serum by LC/MS/MS
Fully-Specified Name
- Component
- 1-deoxymethylsphinganine
- Property
- MCnc
- Time
- Pt
- System
- Ser
- Scale
- Qn
- Method
- LC/MS/MS
Basic Attributes
- Class
- CHEM
- Type
- Laboratory
- First Released
- Version 2.75
- Last Updated
- Version 2.75 (ADD)
- Order vs. Observation
- Both
Formula (Readable)
Reference value <=0.04
Member of these Panels
| LOINC | Long Common Name |
|---|---|
| 102049-4 | Hereditary sensory and autonomic neuropathy type 1 panel - Serum by LC/MS/MS |
Language Variants Get Info
| Tag | Language | Translation |
|---|---|---|
| cs-CZ | Czech (Czechia) | 1-deoxymethylsfinganin: |
| el-GR | Greek (Greece) | 1-δεοξυμεθυλοσφιγγανίνη: Synonyms: 1-δεοξυμεθυλοσφιγγανίνη CHEM LC/MS/MS MCnc Pt Qn Ορός |
| es-ES | Spanish (Spain) | 1-desoximetilesfinganina: Synonyms: Cuantitativo |
| fr-FR | French (France) | 1-déoxyméthylsphinganine: |
| it-IT | Italian (Italy) | 1-deossimetilsfinganina: Synonyms: Chimica Concentrazione di Massa Punto nel tempo (episodio) Siero |
| nl-NL | Dutch (Netherlands) | 1-deoxymethylsfinganine: |
| pl-PL | Polish (Poland) | 1-Deoksymetylosfinganina: |
| zh-CN | Chinese (China) | 1-脱氧甲基二氢神经鞘胺醇: Synonyms: 1-脱氧甲基二氢(神经)鞘胺醇; |
Example Units
| Unit | Source |
|---|---|
| ng/mL | Example UCUM Units |
102052-8 1-Deoxysphingosine [Mass/volume] in Serum by LC/MS/MS
Part Descriptions
LP435914-9 (2S,3R)-2-Amino-4-octadecene-3-ol
Deoxy-sphingolipids are elevated in patients with steatosis compared to those without fatty liver. Those with or without steatoses there is no difference between the different NAFLD subtypes. PMID: 33084982
Source: PubMed Central
Fully-Specified Name
- Component
- (2S,3R)-2-Amino-4-octadecene-3-ol
- Property
- MCnc
- Time
- Pt
- System
- Ser
- Scale
- Qn
- Method
- LC/MS/MS
Basic Attributes
- Class
- CHEM
- Type
- Laboratory
- First Released
- Version 2.75
- Last Updated
- Version 2.75 (ADD)
- Order vs. Observation
- Both
Formula (Readable)
Reference value <=0.05
Member of these Panels
| LOINC | Long Common Name |
|---|---|
| 102049-4 | Hereditary sensory and autonomic neuropathy type 1 panel - Serum by LC/MS/MS |
Language Variants Get Info
| Tag | Language | Translation |
|---|---|---|
| cs-CZ | Czech (Czechia) | 1-deoxysfingosin: |
| el-GR | Greek (Greece) | (2S,3R)-2-άμινο-4-δεκαοκτένιο-3-όλη: Synonyms: (2S,3R)-2-άμινο-4-δεκαοκτένιο-3-όλη CHEM LC/MS/MS MCnc Pt Qn Ορός |
| es-ES | Spanish (Spain) | (2S,3R)-2-Amino-4-octadeceno-3-ol: Synonyms: 1-desoxiesfingosina Cuantitativo |
| fr-FR | French (France) | 1-déoxysphingosine: |
| it-IT | Italian (Italy) | (2S,3R)-2-Ammino-4-ottadecene-3-ol: Synonyms: 1-Deossisfingosina Chimica Concentrazione di Massa Punto nel tempo (episodio) Siero |
| nl-NL | Dutch (Netherlands) | 1-deoxysfingosine: |
| pl-PL | Polish (Poland) | (2S,3R)-2-Amino-4-octadecen-3-ol: Synonyms: 1-Deoksysfingozyna |
| zh-CN | Chinese (China) | (2S,3R)-2-氨基-4-十八烯-3-醇: Synonyms: 1-脱氧鞘氨醇; |
Example Units
| Unit | Source |
|---|---|
| ng/mL | Example UCUM Units |
102051-0 1-deoxysphinganine [Mass/volume] in Serum by LC/MS/MS
Fully-Specified Name
- Component
- 1-deoxysphinganine
- Property
- MCnc
- Time
- Pt
- System
- Ser
- Scale
- Qn
- Method
- LC/MS/MS
Basic Attributes
- Class
- CHEM
- Type
- Laboratory
- First Released
- Version 2.75
- Last Updated
- Version 2.75 (ADD)
- Order vs. Observation
- Observation
Formula (Readable)
Reference value <=0.25
Member of these Panels
| LOINC | Long Common Name |
|---|---|
| 102049-4 | Hereditary sensory and autonomic neuropathy type 1 panel - Serum by LC/MS/MS |
Language Variants Get Info
| Tag | Language | Translation |
|---|---|---|
| cs-CZ | Czech (Czechia) | 1-deoxysfinganin: |
| el-GR | Greek (Greece) | 1-δεοξυ-σφιγγανίνη: Synonyms: 1-δεοξυ-σφιγγανίνη CHEM LC/MS/MS MCnc Pt Qn Ορός |
| es-ES | Spanish (Spain) | 1-desoxiesfinganina: Synonyms: Cuantitativo |
| fr-FR | French (France) | 1-déoxysphinganine: |
| it-IT | Italian (Italy) | 1-deossisfinganina: Synonyms: Chimica Concentrazione di Massa Punto nel tempo (episodio) Siero |
| nl-NL | Dutch (Netherlands) | 1-deoxysfinganine: |
| pl-PL | Polish (Poland) | 1-Deoksysfinganina: |
| zh-CN | Chinese (China) | 1-脱氧鞘氨醇: Synonyms: Ⅰ I Tandem Mass Spectrometry; |
Example Units
| Unit | Source |
|---|---|
| ng/mL | Example UCUM Units |
102050-2 Diabetic diagnosis [Identifier]
Fully-Specified Name
- Component
- Diabetic diagnosis
- Property
- Prid
- Time
- Pt
- System
- ^Patient
- Scale
- Nom
- Method
Basic Attributes
- Class
- MISC
- Type
- Laboratory
- First Released
- Version 2.75
- Last Updated
- Version 2.75 (ADD)
- Order vs. Observation
- Observation
Example Answer List LL6350-4
| Answer | Code | Score | Answer ID |
|---|---|---|---|
| Diabetes Type I | LA33712-3 | ||
| Diabetes Type II | LA33713-1 | ||
| Nondiabetic | LA33714-9 | ||
| Metabolic Syndrome | LA33716-4 | ||
| Impaired glucose tolerance | LA33717-2 | ||
| Unknown Copyright http://snomed.info/sct ID:261665006 Unknown (qualifier value) | LA4489-6 |
Member of these Panels
| LOINC | Long Common Name |
|---|---|
| 102049-4 | Hereditary sensory and autonomic neuropathy type 1 panel - Serum by LC/MS/MS |
Language Variants Get Info
| Tag | Language | Translation |
|---|---|---|
| cs-CZ | Czech (Czechia) | Diagnóza diabetu: |
| el-GR | Greek (Greece) | Διάγνωση διαβήτη: Synonyms: - MISC Nom Prid Pt Ασθενής Διάγνωση Διάγνωση διαβήτη |
| es-ES | Spanish (Spain) | Diagnóstico de diabetes: |
| it-IT | Italian (Italy) | Diagnosi diabetica: Synonyms: Diagnosi tipo di diabete Miscellanea paziente Presenza o Identità Punto nel tempo (episodio) |
| pl-PL | Polish (Poland) | Diagnoza cukrzycy: Synonyms: wynik kategorialny |
| zh-CN | Chinese (China) | 糖尿病诊断: Synonyms: 分类型应答; |
Third Party Copyright
This material includes SNOMED Clinical Terms® (SNOMED CT®) which is used by permission of the International Health Terminology Standards Development Organisation (IHTSDO) under license. All rights reserved. SNOMED CT® was originally created by The College of American Pathologists. "SNOMED" and "SNOMED CT" are registered trademarks of the IHTSDO.
This material includes content from the US Edition to SNOMED CT, which is developed and maintained by the U.S. National Library of Medicine and is available to authorized UMLS Metathesaurus Licensees from the UTS Downloads site at https://uts.nlm.nih.gov.
Use of SNOMED CT content is subject to the terms and conditions set forth in the SNOMED CT Affiliate License Agreement. It is the responsibility of those implementing this product to ensure they are appropriately licensed and for more information on the license, including how to register as an Affiliate Licensee, please refer to https://www.snomed.org/get-snomed or [email protected]<mailto:[email protected]>. This may incur a fee in SNOMED International non-Member countries.